Evermay Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Evermay Wealth Management's DGX Position: Q2 2026 in Review
Evermay Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,265 shares worth $268K. The position accounts for 0.03% of the portfolio, ranked #175.
Evermay Wealth Management first reported a position in DGX in Q4 2019 and has held it in 26 quarters since. The position peaked at $398K in Q4 2021. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Evermay Wealth Management held 1,265 shares of Quest Diagnostics worth $268K as of Q2 2026.
- Evermay Wealth Management left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.03% of Evermay Wealth Management's portfolio in Q2 2026, its #175 holding.
- Evermay Wealth Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 26 quarters since.
- Evermay Wealth Management's Quest Diagnostics position peaked at $398K in Q4 2021.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.